CML cells incubated with niclosamide for different durations, levels of cytochrome c and AIF in the cytosolic fraction were increased after niclosamide treatment (Fig. 4f), which was prior to the activation of caspase-9 and caspase-3. The gene discussed is CASP9; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.